Xiaofei Zhou

5PUBLICATIONS
6CO-AUTHORS
Computational physiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunityTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2021
Author Correction: NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.

Meidi Gu, Xiaofei Zhou, Jee Hyung Sohn

|Jan 13, 2021
Targeting ubiquitin signaling for cancer immunotherapy.

Xiaofei Zhou, Shao-Cong Sun

|Jan 05, 2021
NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.

Meidi Gu, Xiaofei Zhou, Jee Hyung Sohn

|Nov 18, 2020
TRAF2 regulates T cell immunity by maintaining a Tpl2-ERK survival signaling axis in effector and memory CD8 T cells.

Xiaoping Xie, Lele Zhu, Zuliang Jie

|Dec 04, 2019
TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis.

Lele Zhu, Yanchuan Li, Xiaoping Xie

Pageof 1